Unique ID issued by UMIN | UMIN000029410 |
---|---|
Receipt number | R000033608 |
Scientific Title | Videoconference-based CBT for depression: a feasibility study |
Date of disclosure of the study information | 2017/10/16 |
Last modified on | 2019/06/13 17:43:39 |
Videoconference-based CBT for depression: a feasibility study
Videoconference-based CBT for depression
Videoconference-based CBT for depression: a feasibility study
Videoconference-based CBT for depression
Japan |
Major Depression
Psychiatry |
Others
NO
To evaluate the safety, efficacy, and feasibility of videoconference-based CBT for patients with major depression.
Safety,Efficacy
Exploratory
Pragmatic
Phase I,II
1. Baseline reduction score of GRID-Hamilton Depression Rating Scale (GRID-HAMD) at 16wk
2. Drop-out rate
1. Baseline reduction score of GRID-Hamilton Depression Rating Scale (GRID-HAMD) at 28 and40wk
2. Beck Depression Inventory (BDI-II), Ruminative Responses Scale (RRS), Sheehan Disability Scale (SDISS):0,8,16,28,40 wks
3. Quick Inventory of Depressive Symptomatology (QIDS), Euro-Qol(EQ-5D), Session Rating Scale (SRS) at each session
4.Short Working Alliance Inventory (WAI-S):1,8,16 wks
5.Client satisfaction questionnaire (CSQ-8j):8,16,28,40 wks
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
1
Treatment
Behavior,custom |
Videoconference-based CBT for depression
20 | years-old | <= |
70 | years-old | > |
Male and Female
1) Having a diagnosed of DSM-IV Major Depressive Disorder confirmed with the SCID
2) GRID-HAMD-17>=14
3) can attend session more than 8
4) 20 yo <= age <70 yo
5) can obtain written consent
1)No alcohol or substance use disorder in 12 months prior to the screening.
2)No history or concurrent manic or psychotic episode.
3)No other primary DSM-IV Axis I Disorders at screening.
4)No comorbid of antisocial personality disorder.
5)No serious suicidal ideation at screening
6) No organic brain lesions or major cognitive deficits in a year prior to the screening.
7)No severe or unstable medical co-morbidities at screening.
8)No past treatment of individual CBT.
9)No structured psychotherapy during the intervention.
10)Other relevant reason decided by the i-CBT principal investigator.
5
1st name | |
Middle name | |
Last name | Atsuo Nakagawa, MD, PhD |
Keio University School of Medicine
Department of Neuropsychiatry
Shinanomachi 35, Shinjuku-ku, Tokyo, Japan
03-5363-3235
anakagawa@keio.jp
1st name | |
Middle name | |
Last name | Atsuo Nakagawa, MD, PhD |
Keio University School of Medicine
Department of Neuropsychiatry
Shinanomachi 35, Shinjuku-ku, Tokyo, Japan
03-5363-3235
anakagawa@keio.jp
Keio University School of Medicine, Department of Neuropsychiatry
AMED
Japanese Governmental office
Japan
NO
慶應義塾大学医学部・慶應義塾大学病院 (Keio Univerisity)
国立精神・神経医療研究センター (NCNP)
2017 | Year | 10 | Month | 16 | Day |
Unpublished
Completed
2017 | Year | 10 | Month | 03 | Day |
2017 | Year | 10 | Month | 10 | Day |
2017 | Year | 10 | Month | 25 | Day |
2018 | Year | 12 | Month | 31 | Day |
2019 | Year | 04 | Month | 25 | Day |
2019 | Year | 05 | Month | 02 | Day |
2017 | Year | 10 | Month | 04 | Day |
2019 | Year | 06 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033608
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |